Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc.（ACRS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
acrs · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$10.60
+143.1% upside
Low
$10.00
Median: $10 · Last Close: $4.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$10.60
143.1% upside
High Target
$12
175.2%
Low Target
$10
129.4%
Current Price
$4.36
as of today
Based on analyst price targets, the ACRS stock price prediction for the next 12 months ranges from $10 to $12. The consensus ACRS price forecast of $10.60 implies 143.1% upside from the current price of $4.36.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.28 | ↓ 1.78% |
1-day model range: $4.25–$4.31. Peak: $4.31 (-1.78%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACRS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-04-29 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-31 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-09 | Scotiabank | Maintains | Sector Outperform→Sector Outperform |
Wall Street analysts have recently issued updated ratings on Aclaris Therapeutics, Inc. (ACRS) stock. Of the recent 64 rating actions, 8 were upgrades and 7 were downgrades. 16 analysts currently cover ACRS.
分析师推荐趋势
ACRS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$6M
↓ 17.2% YoY
Revenue Next Year
$6M
↑ 2.3% YoY
EPS This Year
$-0.67
EPS Next Year
$-0.76
↑ 14.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACRS EPS of $-0.67 for the current fiscal year, based on estimates from 8 analysts. The ACRS revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ACRS 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ACRS 的共识目标价为 $10.60（+143.1% 上行空间），分析师共识为 Buy。
ACRS 的短期预测（明日）为 $4.28（-1.78%）。
Aclaris Therapeutics, Inc. 在 NASDAQ 上市，代码 ACRS。ACRS 在 2027 年的整体展望偏积极，在覆盖分析师中约 81% 对应 Buy 共识。
常见问题
ACRS 预测 · 8 个问题根据 16 位华尔街分析师，ACRS 的 12 个月平均目标价为 $10.60，最高 $12.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $4.36，隐含约 +143.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.